Target,Name,sequence,label
PTK7,sgc8,CACACTTAGAGTTCTAACTGCTGCGCCGCCGGGAAAATACTGTACG,1
PTK7,sga16,CACACTTAGAGTTCTAGCTGCTGCGCCGCCGGGAAAATACTGTACG,1
PTK7,sgc8c,ATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTaga,1
PTK7,H10-apt1,TGCTGCGCCGCCGGGGAAGGTGCTTGAAAAGAACATGGTACGGTA,1
PTK7,H10-apt2,AGCCGTGCCACCGGGAGTCTACAGGATAGATAAGACGTACGGTA,1
PTK7,H10-apt3,TGCTGCGCCGCCGGGGAAGGTATTTGAAAAGAACATGGTACGGTA,1
PTK7,GYa-apt1,AGCCGCGCCGCCGGGAATGTCAAAGTACGGATATTGGAGCTACTG,1
CD24,CD24A_5,TATGTGGGTGGGTGGGTGGTTATGCTGAGTCAGCCTTGCT,0
AR,DML-7 ,GTTGGGGTCGGGCATGCGTCCGGAGAAGGGCAAACGAGAG,0
MET,CLN0003,TGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCT,0
Vascular endothelial growth factor (VEGF165),SL2-B aptamer,CAATTGGGCCCGTCCGTATGGTGGGT,0
VEGF,hVap1_SST,TCTAGCCCACTGCATAGAGGTAGCTACCGGTG,0
CD30,C2NP,ACTGGGCGAAACAAGTCTATTGACTATGAGC,0
MUC1,MUC1 S2.2,CAGTTGATCCTTTGGATACCCTGG,0
IL-17RA,RA10-6,CTTGGATCACCATAGTCGCTAGTCGAGGCT,0
EGFRvIII, U2 ,TTGACGCTTTATCCTTTTCTTATGGCGGGATAGTTT,0
CD274,PL1,AGAGTATAAAAAGAGTGATGATCTTTTGTAGGTTTT,0
ITGA4,sgc-4e,AATTCGAGTGCGGATGCAAACGCCAGACAGGGGGACAGGA,0
HepG2,Apt-07S,GTACTGTCAATTGGAAGTGGTGTTACGTTGTGTAGTCAAATCAGTG,0
TFRC,XQ-2d,GGGTTAGGGGCTGCTGGCCAGATACTAGATGGTAGGGTTA,0
CD8a,A1,AGCACCCGTGGTAGTGTATCAGGGAGACACTACGTGATGCAGCTTG,0
CD70,Apt928,GGGAAGAGGGCAGGGGAGGGAGGGTGACGCGGAAGAGGCA,0
CD109,S3,TCTGAGAATAGTGGTTTGCTGTATGGTGGGCGTTGAAAGAGGGG,0
ALPL,BG2,CAAGGAATAGGGGTCGGTGTGGGTGGTTATGATTGGCTTCCTTG,0
HER2,ECD_Apt1,CCGCAACCACGACCGAAAGACAACGCAATCTGACACGTGG,0
CA125,Aptamer 2.26,GATTTTAGGGAAGAGAAGGACTTTTATGCCGCCTTG,0
 Nucleolin ,AS1411,GGTGGTGGTGGTTGTGGTGGTGGTGG,0
Thymidine kinase 1,TK1Apt37,CGGTGCAGTGGATACATGCCAGCCGTAGCCATCGTGGATA,0
glucagon receptor (GCGR),GR-3,TAAGTAGGTATCCGTTTGAAAAACTTTTCTGACCGTCCGAC,0
syndrome coronavirus 2 spike (S) protein,S-aptamer-2,GCTCAGGGTCAGGGTTGGGCAGAGGATGTGGGAAGAGCTG,0
IgM,TD05,ACACCGTGGAGGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCGGTG,0
